Therapeutic Research Protocol Dose: 1.0 2.0 mg (= 2040 clicks) Duration: 3 6 weeks Frequency: Daily until target pigmentation observed Cycle Interval: 4 6 weeks off before repeating Goal / Description: Higher-dose schedule used in photoprotection and MC1R activation studies
Four of the five warning letters were to companies (specifically, Xcel Research, Prime Vitality, Summit Research Peptides, and Swisschem) that claimed to distribute GLP-1s for research use only in spite of ample evidence to the contrary
it reflects the legal and ethical framework around unapproved peptides
and provides a list of recommendations compiled from academic journals
Cheng, J., Wang, C., Feng, D., Zheng, R., Xu, Y., Zhang, C
doi: 10.2144/fsoa-2020-0091 210 OrdonezA